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diagnosis between tuberculous pleural effusion
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Abstract
Background: The current study was performed to investigate the potential biomarkers for the differential diagnosis
of tuberculous pleural effusion (TPE) and malignant pleural effusions (MPE).
Methods: Among ninety patients (n = 90) involved in the study, 47 with tuberculous pleural effusion aged from 18
to 70 and 43 with secondary malignant pleural effusion aged from 34 to 78. We tested the pleural levels of TNF-α,
IFN-γ and IL-10 as well as the enzyme activity of ADA2, and then we compared the differential diagnostic
efficiencies of those biochemical parameters with ADA between the two groups.
Results: Our results show that, the concentrations of pleural TNF-α (45.55± 15.85 ng/L), IFN-γ (114.97 ± 27.85 ng/L)
as well as activities of ADA2 (35.71± 10.00 U/L) and ADA (39.39± 10.60 U/L) in tuberculous group were significantly
higher compared to malignant group. Furthermore, according to the ROC curve analysis the thresholds of TNF-α,
IFN-γ, ADA2 and ADA were found to be 30.3 ng/L, 103.65 ng/L, 29.45 U/L, and 39.00 U/L, respectively. TNF-α, IFN-γ
and ADA2 yielded better sensitivity, specificity, and accuracy of the diagnosis than ADA. Our investigation further
revealed that the combinations of TNF-α and ADA2 further increased the specificity and accuracy for the differential
diagnosis.
Conclusion: In conclusion, we found that TNF-α, IFN-γ, ADA and ADA2 all increased in TPE. Combinations of the
TNF-α and ADA2 yielded the best specificity and accuracy for the differential diagnosis of TPE from MPE. Our
investigation suggests that the applications of TNF-α together with ADA2 may contribute to more efficient
diagnosis strategies in the management of discrimination between tuberculous and malignant pleural effusions.
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Most of pulmonary and systemic diseases may be associ-
ated with pleural effusion. It is a common clinical problem
and it has been estimated that there are >800,000 cases/
year in the USA [1]. Tuberculosis and malignant diseases
involving the pleura are the leading causes of pleural
effusion, which has an occurrence of 49.6% and 29.6%,
respectively, especially in the under developed areas
among all pleural effusion cases, respectively [2-5]. Thus,
it is of great clinical significance to explore efficient
biochemical markers for making differential diagnosing
of tuberculous pleural effusion (TPE) from malignant
pleural effusion (MPE). The diagnosis of TPE is made
by detecting Mycobacterium tuberculosis in the pleural
fluids and/or pleural biopsy specimens, or demonstrating
caseation granulomas in pleura [6]. However, only 10-35%
of biological culture and 20-81% of molecular tests reveal
mycobacteria in pleural fluids, and pleural biopsy dem-
onstrates granulomas in 56-82% of samples [7-10]. In
addition, the financial problem is a burden for the pa-
tients as well. Furthermore, the discrimination from MPE,
which is mainly diagnosed based on the pathological
methods, is still a challenge.
It is reported that adenosine deaminase (ADA), tumor
necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ),
interlukine-12 (IL-12), interlukine-18 (IL-18), interlukine-
10 (IL-10), interlukine-27 (IL-27), Immunosuppressive
acidic protein (IAP), and soluble IL-2 receptor could serve
as differential diagnosis biomarkers for pleural effusion
caused by TB or malignant diseases [7,11,12]. Adenosine
deaminase (ADA), a purine-degrading enzyme implicated
in mononuclear phagocyte maturation, has been re-
ported to accumulate in the pleural fluid of TB patients
and being predict TB pleurisy with high sensitivity and
specificity at 95% and 90% respectively [6]. The accu-
mulation of ADA in pleural fluid results mainly from
one of its isoforms, ADA2, with which a diagnosis of tu-
berculous pleurisy could be verified [13]. In the past
decade, researchers demonstrated that both tuberculous
and malignant pleural effusions show marked increase
of TNF-α [14-17]. And the up-regulated IFN-γ and IL-
10 in fluid can be diagnostic parameters for tuberculous
pleural effusion as well. Most recently, interlukine (IL)-
27, a member of IL-12 family, has been verified useful
in diagnosing TPE or discriminating pleural effusions
caused by tuberculosis from other medical situations
[12,18]. However, none of those is widely used in clinical
practice currently but it is only restricted to research
settings.
In this present study, we aimed at exploring the po-
tential series of diagnostic biomarkers. In order to figure
out the clinical significance of these diagnostic parame-
ters for the discriminating diagnosis of tuberculous and
malignant pleural effusions, concentrations of TNF-α,
IFN-γ and IL-10 and enzyme activity of ADA2 were
m e a s u r e da n dc o m p a r e dw i t hA D Aa c t i v i t y .
Methods
Patients and sample collection
A total of 90 patients (n=90) admitted in Henan Tuber-
culosis Hospital between Jun. 2010 and May. 2012 were
involved in this research (Table 1). All patients have been
diagnosed based on clinical symptoms, pleural effusion
analysis, and/or pleural biopsy specimen observation. Ac-
cordingly, the subjects were determined as tuberculous
pleural effusion based on the presence of either positive
staining or culture for M. tuberculosis in the pleural fluid,
sputum or pleural biopsy specimen or caseating granu-
lomas on pleural biopsy. Secondary malignant pleural
effusion diagnosis was based on the determination of
malignant cells on cytological examination or in a biopsy
specimen, or by histologically determined primary malig-
nance with the exclusion of any other cause of pleural
effusion. Among all the 43 patients, there were 26 pa-
tients with lung cancer (60.5%), 6 patients with breast
cancer (14.0%), 7 metastatic cancer patients with unknown
idiopathy (16.3%), and 4 patients with stomach, pancreatic
or ovary cancer (9.3%). All pleural fluid samples were col-
lected by thoracentesis prospectively before the patients
undergone any medical treatments. Collected samples
from all the patients were centrifuged and kept in freezer
in −70°C.
This study was approved by the Ethics Committee of
Henan Tuberculosis Hospital. Study participants and/or
their legal guardians granted written-informed consent.
Determination of cytokines’ concentration and enzyme
activities of ADA and ADA2
Enzyme-linked immunosorbant assay (ELISA) was per-
formed according to manufacturer’s instructions to de-
termine the pleural concentrations of TNF-α, IFN-γ and
IL-10 using commercial kits (Biosource). Pleural enzyme
activity of ADA and ADA2 were determined by spectro-
photometric method according to Muraoka’s [19] method.
In detail, the catalyzed enzyme activity of ADA or ADA2
was determined by quantifying hypoxanthine liberated
from the substrate (1 U/L) under the atmosphere of 37°C
and pH7.1. The substrate of ADA was composed of ad-
enosine (6 mM), γ- oxoglutarate (1.1 mM), ADP (1 mM)
and glutamate dehydrogenase (18 U/L). And the ADA2
Table 1 Clinical information of patients
Group Case
Gender Age
MF (  x ±s)
Tuberculous 47 29 18 51.3±11.8
Malignant 43 23 20 55.5±12.4
Comparison between gender χ
2 = 0.263,P> 0.05.
Comparison between age t=1.646,P> 0.05.
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the presence of erythro-9-(2-hydroxy-3- nonyl) adenine
hydrochloride (EHNA, 0.1 mM). The enzyme activities ab-
sorbance was read at 340 nm using automatic biochemical
analyzer (Olympus AU600). Here, the enzyme activity
(1 U/L) was defined as 1 μM hypoxanthine liberating from
catalyzed adenosine per minute. All samples were assayed
in duplicate.
Statistical analysis
Computerized statistical analyses were performed using
the Statistical Package for the Social Sciences (SPSS),
version 17.0. The variances of different biomarkers among
different groups were analyzed using Mann–Whitney
U-test, the comparison of sensitivity and specificity was
analyzed by χ
2 test. Sensitivity and specificity values
providing the best test performance and the area under
the curve (AUC) were calculated using a receiver operat-
ing characteristic (ROC) curve analysis. In all statistical
analyses, a two-tailed p value ≤0.05 was considered statis-
tically significant. Data were presented as mean±standard
error (SE).
Results
Clinical information of patients
In our study neither age nor gender has any statistical
significance between groups (Table 1).
Concentration of pleural cytokines and enzyme activities
of ADA and ADA2
We assayed the concentrations of pleural TNF-α, IFN-γ,
IL-10 as well as the activities of ADA and its isoenzyme,
ADA2. Then we compared the diagnostic efficiencies of
the cytokines and ADA2 with ADA, which is well known
for the high diagnostic value for tuberculous pleural ef-
fusion. The level of TNF-α was up-regulated significantly
in tuberculous group from 17.18 ± 4.84 ng/L to 45.55 ±
15.85 ng/L compared to malignant group. In addition,
the pleural IFN-γ was higher in tuberculous group
(114.97± 27.85 ng/L) than in malignant group (87.15 ±
18.77 ng/L) as well (p< 0.001). The enzyme activities
of ADA in tuberculous and malignant pleural fluid
were 39.39± 10.60 U/L and 32.16± 6.99 U/L respect-
ively. The ADA2 activity was 35.71±10.00 U/L and
20.87± 4.53 U/L in tuberculous and malignant pleural
effusion respectively as shown in Table 2. However,
there was no statistical significance on the level of pleural
IL-10 between these two groups.
Differential diagnostic values of TNF-α, IFN-γ, ADA and
ADA2
ROC curve analysis was introduced to evaluate the cut-off
values of pleural TNF-α,I F N - γ,A D Aa n dA D A 2 (Figure 1).
The thresholds were found to be 30.3 ng/L, 103.65 ng/L,
39.00 U/L and 29.45 U/L respectively (Table 3). Unfortu-
nately, when compared to ADA, no statistical significance
was found on the area under the curve (AUC) value of
TNF-α,I F N - γ and ADA2 (p>0.05) (Table 3). But the
AUC for all of these bio parameters are greater than 0.5,
TNF-α (0.976), IFN-γ (0.831) and ADA2 (0.844), indi-
cating that TNF-α,I F N - γ and ADA2 are reliable for the
clinical diagnosis of TPE.
With a cut-off value of 30.3 ng/L, the sensitivity of
TNF-α for differential diagnosis of TPE from MPE was
83%, with the specificity of 97% and accuracy of 90%
(Table 3). Also as shown in Table 3, with a cut-off value
of 103.65 ng/L, the sensitivity of IFN-γ was 80.9%, speci-
ficity was 81.4% and accuracy was 81.1%. Furthermore,
our data indicated that ADA2 yielded slightly better speci-
ficity of 97% and accuracy of 86.7% than ADA but equiva-
lent sensitivity of 76.6% for the differential diagnosis of the
diseases (Table 3).
Combined-diagnostic value of TNF-α, IFN-γ and ADA2
The question of the possibility of the combinations of two
or three of the parameters would improve the diagnostic
sufficiency for differentiating tuberculous pleural effusion
from malignancy is raised. As a result, we further investi-
gated the potential combined-diagnostic value of TNF-α,
IFN-γ and ADA2. Parallel tests were introduced in our
analysis to evaluate the differential diagnostic significances
of the biochemical parameters of interests for tuberculous
or malignant pleural effusion. When two or three parame-
ters of TNF-α,I F N - γ and ADA2 were used for diagnosis,
the measurement of TNF-α plus ADA2 yielded the highest
specificity (97.7%) and accuracy (88.3%) but slight increase
in sensitivity (78.9%) (Table 4) for discriminating tubercu-
lous pleural effusion from malignant pleural effusion.
Table 2 Pleural fluid enzyme activities of ADA and ADA2, concentrations of TNF-α, IFN-γ and IL-10 (±s)
Group n ADA
(U/L)
ADA2
(U/L)
ADA2/ADA
(%)
TNF-α
(ng/L)
IFN-γ
(ng/L)
IL-10
(ng/L)
Tuberculous 47 39.39±10.60 35.71±10.00 90.63 45.55± 15.85 114.97± 27.85 6.12±2.31
Malignant 43 32.16±6.99 20.87±4.53 64.89 17.18± 4.84 87.15±18.77 6.20±2.29
t 5.74 12.76 56.89 12.26 5.28 0.994
P <0.001 <0.001 <0.001 <0.001 <0.001 >0.05
n = number of subject; Values are mean ± SD.
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Tuberculosis and secondary malignant diseases are the
leading causes of pleural effusion. Although the pleural
fluids were mainly composed of lymphocytes both in
TPE and MPE, clinical treatments and prognosis vary
significantly. Thus, differential determination plays a key
role in the clinical procedure of pleural effusion. Tubercu-
lous pleurisy is diagnosed based on the positive culture of
pleural M. tuberculosis or demonstrating the characteristic
caseation granulomas in pleural biopsy specimens [6].
However, histological or bacteriological confirmation for
tuberculous pleurisy is of lower sensitivity or accuracy.
T h el a c ko fm o r ee f f i c i e n td i a g n o s t i cc r i t e r i ad r o v ei n -
vestigators to explore a specific marker for diagnosis of
diseases.
In the past decades, series of bio-parameters were
reported to play a role in the differential diagnosis of
tuberculous and malignant pleural effusions. Among
which, ADA, a purine-degrading enzyme that catalyze
the conversion of adenosine and deoxyadenosine to in-
osine and deoxyinosine with the release of ammonia, is
the most sensitive and specific marker for tuberculosis
pleurisy diagnosis [20-23]. Meanwhile, ADA2,i s o f o r m
of ADA, was reported to be a useful biochemical marker
for the early diagnosis of tuberculous pleural effusion
and differentiate tuberculous pleural effusion from non-
tuberculous origins efficiently [24]. As shown in this
study, the sensitivity and specificity yielded for ADA on
the diagnosis of tuberculosis pleurisy are 76.6% and 83.7%,
respectively, which are in agreement with previous studies.
Based on these results, we further confirmed the clinical
significance of ADA2. Meanwhile, the ratio of ADA2 to
the total ADA (mean: 90.63%) increased significantly in
the tuberculosis group, indicating the increased pleural
ADA2 accounts for the high activity of ADA in the effu-
sion fluid. As a delayed hypersensitivity reaction, TB was
resistant by Th1 type immune response of the body, which
enables ADA2 up regulated in the pleural fluid. As shown
in our study, pleural ADA2 yielded the great sensitivity of
76.6% and the highest specificity of 97% on the diagnosis
of tuberculous pleurisy. Unfortunately, no statistical sig-
nificance was found when compared with ADA. However,
it was reported that ADA activity may be lower at the
early stage of tuberculous pleurisy and the high activities
may decrease long after onset of the disease as well [13].
Recently it was reported that the increased ADA activ-
ity was not restricted in tuberculous pleurisy but in the
pleural fluid associated with pyothorax, lymphoma or
ILS [6]. Therefore we further investigated other diag-
nostic bio parameters, hoping to discover a reliable
biomarker for the diagnosis of tuberculosis associated
pleural effusion.
Tumor necrosis factor-α (TNF-α), a small polypeptide,
functions on biological and immunological processes. It
is a pro-inflammatory cytokine, which is synthesized by
lymphocytes and monocytes/macrophages [25]. As a
Th1 subset member, it plays an important role in anti-
inflammation reaction and tumor resistant process. Pre-
vious literatures demonstrated significant accumulated
TNF-α in pleural fluid of TB [26] comparing to the malig-
nant pleural effusion. As expected, we detected the up-
regulated pleural level of TNF-α (45.55±15.85 ng/L) in
the TB pleural fluid, which is significantly higher than
that of malignant (17.18±4.84 ng/L) group. Meanwhile,
with a cut off of 30.3(ng/L), the sensitivity and specifi-
city of TNF-α for tuberculous pleurisy diagnosis were
determined to be the highest, 83% and 97% respectively,
which is in agreement of previous findings [25]. Therefore,
Figure 1 Receiver Operative Characteristic (ROC) curves of
pleural TNF-α, IFN-γ, ADA and ADA2. The cut-off values of TNF-α,
IFN-γ, ADA and ADA2 were determined by the best sum of
sensitivity and specificity on the ROC curve. Diagonal line indicates
the line of no discrimination.
Table 3 Differential diagnostic significance of TNF-α, IFN-γ and ADA2
Bio-parameter AUC Cut-off Sensitivity (%) Specificity (%) Accuracy (%)
TNF-α 0.976* 30.3 (ng/L) 83.0 97.0 90.0
IFN-γ 0.831
# 103.65 (ng/L) 80.9 81.4 81.1
ADA2 0.844
## 29.45 (U/L) 76.6 97.0 86.7
ADA 0.779 39.00 (U/L) 76.6 83.7 80.0
Compared with ADA*χ
2 = 0.201, p> 0.05;
#χ
2 = 0.655, p > 0.05;
##χ
2 = 0.81, p > 0.05.
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ing diagnosis of pleural effusions, from TB and malignant
outcomes.
Another Th1 subset cytokine, IFN-γ,s e c r e t e db ya c -
tivated lymphocytes enhances the anti-myobacterial
properties of macrophages and induces TNF. Both
IFN-γ and TNF-α present near the local concentra-
tions area in pleural fluid of TB, which are useful for
the bacilli elimination and granuloma formation [27].
In addition, activated by TNF, macrophages produce
large amount of nitric oxide (NO), with which, could
eliminate M. tuberculosis efficiently [28]. Our study
showed a significant increase of IFN-γ (114.97±27.85 ng/L)
in pleural fluid of TB than that of malignant cases
(87.15 ±18.77 ng/L). With a cut off of 103.65(ng/L), it
yielded mild sensitivity (80.9%) and specificity (81.4%),
although it is less powerful than TNF-α.
However, when compared with IFN-γ and TNF-α,t h e
potential diagnostic value of IL-10 was poorly investigated.
According to Olobo’s report [28], pleural IL-10 was accu-
mulated in TB. However, in this study, we found that there
was no statistical significance of pleural level of IL-10 in
TB and malignant pleural effusions.
In addition, ROC curve analysis indicates the area
under the curve (AUC) of IFN-γ,T N F - α and ADA2 were
0.831, 0.976 and 0.844 respectively. Therefore we con-
firmed that all of these three bio parameters are of great
reliability for the diagnosis of tuberculous pleural effusion.
With the greatest AUC (0.976), the sensitivity, specificity
and accuracy of TNF-α are 83%, 97% and 90% respect-
ively. ADA2 yielded comparable diagnostical values, AUC
was 0.844, sensitivity was 76.6%, specificity was 97%, and
accuracy was 86.7%. With the sensitivity of 80.9% and
specificity of 81.4%, IFN-γ was of less clinical accuracy
than TNF-α and ADA2.H o w e v e r ,I L - 1 0w a sf o u n dn o t
to be useful for the diagnosis.
Based on the fact above, IFN-γ, TNF-α,A D Aa n dA D A 2
would be the preferred choice to be used to discriminate if
the patient is TPE or MPE. But in the clinical practices, to
avoid any misdiagnose of diseases, the discriminating diag-
nosis is determined by taking many factors into account,
rather than by testing any single method [18]. The com-
binations of two or more biomarkers are required to be
positive for a diagnosis to be made, which increased the
specificity at the expense of sensitivity. Although TNF-α
or ADA2 were shown to be effective when used indi-
vidually for differential diagnosing of TPE from MPE,
the combinations of these two biomarkers should result
in an improved sensitivity or specificity in reality. Our
findings supported that the combination of TNF-α and
ADA2 result in the optimal sensitivity of 78.9%, specifi-
city of 97.7% and accuracy of 88.3%. Therefore, the
combinations of TNF-α and ADA2 could effectively ad-
dress the challenge of distinguishing tuberculous pleural
effusion from malignant pleural effusion.
Conclusion
In conclusion, our investigation suggested that, compared
to malignant pleural effusion, IFN-γ,T N F - α, ADA and
ADA2 all increased in tuberculous pleural effusion. In
addition, combinations of TNF-α and ADA2 yielded the
optimal clinical accuracy on making differential diag-
nose between TPE and MPE.
The number of patients in this study would not be suffi-
cient to deduce a conclusion for a diagnostic accuracy
study. A future research with a larger sample analysis will
be done to confirm the conclusion drawn in this study.
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